276 related articles for article (PubMed ID: 36646159)
1. Sanhuang xiexin decoction synergizes insulin/PI3K-Akt/FoxO signaling pathway to inhibit hepatic glucose production and alleviate T2DM.
Chen D; Chen X; He C; Xiao C; Chen Z; Chen Q; Chen J; Bo H
J Ethnopharmacol; 2023 Apr; 306():116162. PubMed ID: 36646159
[TBL] [Abstract][Full Text] [Related]
2. A bioinformatics and transcriptomics based investigation reveals an inhibitory role of Huanglian-Renshen-Decoction on hepatic glucose production of T2DM mice via PI3K/Akt/FoxO1 signaling pathway.
Wu F; Shao Q; Xia Q; Hu M; Zhao Y; Wang D; Fang K; Xu L; Zou X; Chen Z; Chen G; Lu F
Phytomedicine; 2021 Mar; 83():153487. PubMed ID: 33636476
[TBL] [Abstract][Full Text] [Related]
3. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
[TBL] [Abstract][Full Text] [Related]
4. Scutellariae Radix and Coptidis Rhizoma Improve Glucose and Lipid Metabolism in T2DM Rats via Regulation of the Metabolic Profiling and MAPK/PI3K/Akt Signaling Pathway.
Cui X; Qian DW; Jiang S; Shang EX; Zhu ZH; Duan JA
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30453687
[No Abstract] [Full Text] [Related]
5. The effect of Liuwei Dihuang decoction on PI3K/Akt signaling pathway in liver of type 2 diabetes mellitus (T2DM) rats with insulin resistance.
Dai B; Wu Q; Zeng C; Zhang J; Cao L; Xiao Z; Yang M
J Ethnopharmacol; 2016 Nov; 192():382-389. PubMed ID: 27401286
[TBL] [Abstract][Full Text] [Related]
6. Alleviation of Fufang Fanshiliu decoction on type II diabetes mellitus by reducing insulin resistance: A comprehensive network prediction and experimental validation.
Dai W; Chen C; Dong G; Li G; Peng W; Liu X; Yang J; Li L; Xu R; Hu X
J Ethnopharmacol; 2022 Aug; 294():115338. PubMed ID: 35568115
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs.
Wang H; Tan H; Zhan W; Song L; Zhang D; Chen X; Lin Z; Wang W; Yang Y; Wang L; Bei W; Guo J
J Ethnopharmacol; 2021 Jun; 274():114056. PubMed ID: 33771638
[TBL] [Abstract][Full Text] [Related]
8. Ameliorative effects of mangiferin derivative TPX on insulin resistance via PI3K/AKT and AMPK signaling pathways in human HepG2 and HL-7702 hepatocytes.
Fan X; Jiao G; Pang T; Wen T; He Z; Han J; Zhang F; Chen W
Phytomedicine; 2023 Jun; 114():154740. PubMed ID: 36965373
[TBL] [Abstract][Full Text] [Related]
9. The 15-hydroxyprostaglandin dehydrogenase inhibitor SW033291 ameliorates abnormal hepatic glucose metabolism through PGE
Liang M; Wang L; Wang W
Cell Signal; 2023 Aug; 108():110707. PubMed ID: 37164143
[TBL] [Abstract][Full Text] [Related]
10. Eurocristatine, a plant alkaloid from Eurotium cristatum, alleviates insulin resistance in db/db diabetic mice via activation of PI3K/AKT signaling pathway.
Zhang H; Hui J; Yang J; Deng J; Fan D
Eur J Pharmacol; 2020 Nov; 887():173557. PubMed ID: 32946868
[TBL] [Abstract][Full Text] [Related]
11. A diarylheptanoid compound from Alpinia officinarum Hance ameliorates high glucose-induced insulin resistance by regulating PI3K/AKT-Nrf2-GSK3β signaling pathways in HepG2 cells.
Zhang XG; Liu AX; Zhang YX; Zhou MY; Li XY; Fu MH; Pan YP; Xu J; Zhang JQ
J Ethnopharmacol; 2022 Sep; 295():115397. PubMed ID: 35605918
[TBL] [Abstract][Full Text] [Related]
12. Chemical Constituents and Hypoglycemic Mechanisms of
Li Z; Zeng M; Geng K; Lai D; Xu Z; Zhou W
Molecules; 2023 Mar; 28(6):. PubMed ID: 36985655
[TBL] [Abstract][Full Text] [Related]
13. Artichoke (Cynara scolymus L.) water extract alleviates palmitate-induced insulin resistance in HepG2 hepatocytes via the activation of IRS1/PI3K/AKT/FoxO1 and GSK-3β signaling pathway.
Deng A; Wang Y; Huang K; Xie P; Mo P; Liu F; Chen J; Chen K; Wang Y; Xiao B
BMC Complement Med Ther; 2023 Dec; 23(1):460. PubMed ID: 38102588
[TBL] [Abstract][Full Text] [Related]
14. Xanthosine, a purine glycoside mediates hepatic glucose homeostasis through inhibition of gluconeogenesis and activation of glycogenesis via regulating the AMPK/ FoxO1/AKT/GSK3β signaling cascade.
Ahmed SA; Sarma P; Barge SR; Swargiary D; Devi GS; Borah JC
Chem Biol Interact; 2023 Feb; 371():110347. PubMed ID: 36627075
[TBL] [Abstract][Full Text] [Related]
15. Exploring the protective effect of ShengMai-Yin and Ganmaidazao decoction combination against type 2 diabetes mellitus with nonalcoholic fatty liver disease by network pharmacology and validation in KKAy mice.
Li S; Qian Y; Xie R; Li Y; Jia Z; Zhang Z; Huang R; Tuo L; Quan Y; Yu Z; Liu J; Xiang M
J Ethnopharmacol; 2019 Oct; 242():112029. PubMed ID: 31216433
[TBL] [Abstract][Full Text] [Related]
16. The therapeutic mechanism of Yuye decoction on type 2 diabetes mellitus based on network pharmacology and experimental verification.
Guo F; Yao L; Zhang W; Chen P; Hao R; Huang X; Jiang J; Wu S
J Ethnopharmacol; 2023 May; 308():116222. PubMed ID: 36828194
[TBL] [Abstract][Full Text] [Related]
17. Phlorizin from Lithocarpus litseifolius [Hance] Chun ameliorates FFA-induced insulin resistance by regulating AMPK/PI3K/AKT signaling pathway.
Zhao H; Zhai BW; Zhang MY; Huang H; Zhu HL; Yang H; Ni HY; Fu YJ
Phytomedicine; 2024 Jul; 130():155743. PubMed ID: 38824822
[TBL] [Abstract][Full Text] [Related]
18. Melatonin treatment improves human umbilical cord mesenchymal stem cell therapy in a mouse model of type II diabetes mellitus via the PI3K/AKT signaling pathway.
Aierken A; Li B; Liu P; Cheng X; Kou Z; Tan N; Zhang M; Yu S; Shen Q; Du X; Enkhbaatar BB; Zhang J; Zhang R; Wu X; Wang R; He X; Li N; Peng S; Jia W; Wang C; Hua J
Stem Cell Res Ther; 2022 Apr; 13(1):164. PubMed ID: 35414044
[TBL] [Abstract][Full Text] [Related]
19. Coronarin A modulated hepatic glycogen synthesis and gluconeogenesis via inhibiting mTORC1/S6K1 signaling and ameliorated glucose homeostasis of diabetic mice.
Huang SL; Xie W; Ye YL; Liu J; Qu H; Shen Y; Xu TF; Zhao ZH; Shi Y; Shen JH; Leng Y
Acta Pharmacol Sin; 2023 Mar; 44(3):596-609. PubMed ID: 36085523
[TBL] [Abstract][Full Text] [Related]
20. Hirsutine ameliorates hepatic and cardiac insulin resistance in high-fat diet-induced diabetic mice and in vitro models.
Hu W; Li M; Sun W; Li Q; Xi H; Qiu Y; Wang R; Ding Q; Wang Z; Yu Y; Lei H; Mao Y; Zhu YZ
Pharmacol Res; 2022 Mar; 177():105917. PubMed ID: 34597809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
